Effect of simvastatin on human skeletal muscle 25) Hypercholesterolemic participants (Danes) took statin for 5 years in average (n=10).
The control group was matched for age, gender, body weight, body mass index, body fat (%), and maximum oxygen intake (n=9). ＊, p≦0.05. See text for details. Figure 7 Statin use and risk of diabetes mellitus in postmenopausal women 44) Postmenopausal women (50-79 years old, n=153,840）were followed for 7 years, and there were 10,242 incident cases of DM. Hazard ratio was significantly greater in the statin user than in the non-user. BMI, body mass index. standard therapy 47) Type Ⅱ diabetics with CHD risks were randomly assigned to intensive therapy targeting to lowering HbA1c levels to 6 % from 8.1% or to standard therapy lowering HbA1c to 7.0 to 7.9 %. The therapy was discontinued at 3.5 years because mortality increased significantly and no significant reduction of major cardiovascular events was observed in the intensive therapy group. 
